Patents and Public Health Legalising the Policy Thoughts in the Doha TRIPS Declaration of 14 November 2001
Do patents rules prevent countries from acquiring affordable medicines? A number of legal experts and governments have felt that the WTO, in particular the TRIPS Agreement, forces countries to favour patents over public health. The WTO sought to settle this dispute by concluding the Public Health De...
Bewaard in:
Hoofdauteur: | Law, Andrew (auth) |
---|---|
Formaat: | Elektronisch Hoofdstuk |
Taal: | Engels |
Gepubliceerd in: |
Nomos Verlagsgesellschaft mbH & Co. KG
2009
|
Reeks: | Munich Intellectual Property Law Center - MIPLC
|
Onderwerpen: | |
Online toegang: | DOAB: download the publication DOAB: description of the publication |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|
Gelijkaardige items
-
Patents in the Food Sector A Retrospective with Special Emphasis on the TRIPs Agreement
door: Willnegger, Eva
Gepubliceerd in: (2008) -
Patent Strategy in Pharmaceutical Industry: Are additional patents valuable?
door: Donghi, Monica
Gepubliceerd in: (2014) -
Patenting Proteomics Patentability and Scope of Protection of Three-Dimensional Protein Structure Claims under German, European and US law
door: Schuster, Martina
Gepubliceerd in: (2010) -
Patentability Requirements for Nanotechnological Inventions An Approach from the European Patent Convention Perspective
door: Cisneros, Mario
Gepubliceerd in: (2009) -
Second Generation Patents in Pharmaceutical Innovation
door: Ahn, Hyewon
Gepubliceerd in: (2014)